ESR1 and breast carcinoma: Although CCAT2 has been reported to promote tumorigenesis in multiple types of cancer [25,30], low expression of CCAT2 in estrogen receptor α (ERα) positive luminal subtype of breast cancer tumors was observed in [24] and our current study.